First Tracks Biotherapeutics, Inc.

NasdaqGS:TRAX Stock Report

Market Cap: US$1.6b

First Tracks Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TRAX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Apr 26SellUS$64,999,990EcoR1 Capital, LLCCompany4,705,575US$13.81

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TRAX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies290.0000831%
Individual Insiders655,5091.88%
Public Companies821,9172.36%
Hedge Funds3,174,5199.1%
Institutions8,762,21425.1%
General Public21,478,19361.6%

Dilution of Shares: TRAX only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 37.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.1%
EcoR1 Capital, LLC
3,174,519US$148.4m0%4.87%
5.87%
FMR LLC
2,047,161US$95.7m0%no data
5.63%
BlackRock, Inc.
1,963,541US$91.8m0%no data
4.71%
Vanguard Capital Management, LLC
1,643,129US$76.8m0%no data
2.77%
State Street Investment Management
968,234US$45.3m0%no data
2.36%
Sanofi
821,917US$38.4m0%2.19%
1.42%
Geode Capital Management, LLC
497,023US$23.2m0%no data
1.42%
Daniel Faga
496,684US$23.2m0%no data
0.95%
Vanguard Portfolio Management, LLC
331,658US$15.5m0%no data
0.83%
Federated Hermes, Inc.
290,000US$13.6m0%0.02%
0.65%
Charles Schwab Investment Management, Inc.
226,724US$10.6m0%no data
0.21%
Financial Enhancement Group LLC
74,450US$3.5m0%0.42%
0.2%
BNY Asset Management
69,813US$3.3m0%no data
0.18%
Deutsche Asset & Wealth Management
62,117US$2.9m0%no data
0.17%
Invesco Capital Management LLC
58,392US$2.7m0%no data
0.16%
Moody Aldrich Partners, LLC
54,316US$2.5m0%0.48%
0.15%
Fisher Asset Management, LLC
51,549US$2.4m0%no data
0.12%
Paul Lizzul
42,669US$2.0m0%no data
0.12%
Goldman Sachs Asset Management, L.P.
40,769US$1.9m0%no data
0.11%
John Schmid
37,652US$1.8m0%no data
0.1%
Citigroup Inc.
36,199US$1.7m0%no data
0.1%
Dimensional Fund Advisors LP
34,756US$1.6m0%no data
0.089%
Tema ETFs LLC
30,907US$1.4m0%0.05%
0.08%
Y-Intercept (Hong Kong) Limited
28,084US$1.3m0%0.03%
0.074%
Rafferty Asset Management, LLC
25,861US$1.2m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/12 21:36
End of Day Share Price 2026/08/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

First Tracks Biotherapeutics, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBarclays
Emily BodnarH.C. Wainwright & Co.
Anupam RamaJ.P. Morgan